RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCDA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for BioCardia, Inc. stock price on Wednesday moving between $2.85 and $3.19
(Updated on Jul 03, 2024)

Buy or Hold candidate since Jun 03, 2024 Loss -32.35% PDF

The BioCardia, Inc. stock price gained 1.70% on the last trading day (Wednesday, 3rd Jul 2024), rising from $2.94 to $2.99. During the last trading day the stock fluctuated 11.93% from a day low at $2.85 to a day high of $3.19. The price has fallen in 6 of the last 10 days and is down by -15.54% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 37 thousand shares were bought and sold for approximately $110.51 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 159.95% during the next 3 months and, with a 90% probability hold a price between $5.07 and $17.52 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCDA Signals & Forecast

The BioCardia, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.96 and $2.56. A breakdown below any of these levels will issue sell signals. BioCardia, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 30, 2024, and so far it has fallen -42.50%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for BioCardia, Inc. stock

BioCardia, Inc. finds support from accumulated volume at $2.97 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.340 between high and low, or 11.93%. For the last week, the stock has had daily average volatility of 9.70%.

Our recommended stop-loss: $2.80 (-6.40%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (BCDA) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect BioCardia, Inc. to open at $3.01, and during the day (based on 14 day Average True Range), to move between $2.59 and $3.39, which gives a possible trading interval of +/-$0.395 (+/-13.23%) up or down from last closing price. If BioCardia, Inc. takes out the full calculated possible swing range there will be an estimated 26.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.97 (0.67%) than the resistance at $3.43 (14.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioCardia, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioCardia, Inc. stock to perform well in the short-term.

Current score: 2.706 Buy Candidate Unchanged

Predicted Opening Price for BioCardia, Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$3.01 ( 0.669%) $2.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCDA

Fibonacci Support & Resistance Levels

Level Price
R3 3.35 12.04%
R2 3.22 7.70%
R1 3.14 5.01%
Price 2.99
S1 2.88 -3.67%
S2 2.80 -6.36%
S3 2.67 -10.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.72 24.41%
R2 3.54 18.39%
R1 3.43 14.72%
Price 2.99
S1 2.97 -0.669%
S2 2.90 -3.01%
S3 2.83 -5.35%

FAQ

What is the symbol for BioCardia, Inc. Stock and on which exchange is it traded?
The symbol for BioCardia, Inc. is BCDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioCardia, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioCardia, Inc. stock to perform well in the short-term.

How to buy BioCardia, Inc. Stock?
BioCardia, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioCardia, Inc. Stock.

What's the current price of BioCardia, Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an BioCardia, Inc. (BCDA) share was $2.99.

What is the 52-week high and low for BioCardia, Inc. Stock?
The 52-week high for BioCardia, Inc. Stock is $5.69 and the 52-week low is $0.301.

What is the market capitalization of BioCardia, Inc. Stock?
As of the Jul 03, 2024, the market capitalization of BioCardia, Inc. is 5.443M.

When is the next earnings date for BioCardia, Inc.?
The upcoming earnings date for BioCardia, Inc. is Aug 14, 2024.
Click to get the best stock tips daily for free!

About BioCardia, Inc.

BioCardia. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture... BCDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT